| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2080399 | Drug Discovery Today | 2011 | 6 Pages |
Abstract
Here, we compare the entire compound collections of Bayer HealthCare and Schering AG with respect to structural identities, similarities and physico-chemical properties. We discuss possible consequences stemming from unexpected findings in light of new collaborative models in pharmaceutical research.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Jens Schamberger, Michael Grimm, Andreas Steinmeyer, Alexander Hillisch,